» Articles » PMID: 28045715

Oncologic Procedures Amenable to Fluorescence-guided Surgery

Abstract

Objective: Although fluorescence imaging is being applied to a wide range of cancers, it remains unclear which disease populations will benefit greatest. Therefore, we review the potential of this technology to improve outcomes in surgical oncology with attention to the various surgical procedures while exploring trial endpoints that may be optimal for each tumor type.

Background: For many tumors, primary treatment is surgical resection with negative margins, which corresponds to improved survival and a reduction in subsequent adjuvant therapies. Despite unfavorable effect on patient outcomes, margin positivity rate has not changed significantly over the years. Thus, patients often experience high rates of re-excision, radical resections, and overtreatment. However, fluorescence-guided surgery (FGS) has brought forth new light by allowing detection of subclinical disease not readily visible with the naked eye.

Methods: We performed a systematic review of clinicatrials.gov using search terms "fluorescence," "image-guided surgery," and "near-infrared imaging" to identify trials utilizing FGS for those received on or before May 2016.

Inclusion Criteria: fluorescence surgery for tumor debulking, wide local excision, whole-organ resection, and peritoneal metastases.

Exclusion Criteria: fluorescence in situ hybridization, fluorescence imaging for lymph node mapping, nonmalignant lesions, nonsurgical purposes, or image guidance without fluorescence.

Results: Initial search produced 844 entries, which was narrowed down to 68 trials. Review of literature and clinical trials identified 3 primary resection methods for utilizing FGS: (1) debulking, (2) wide local excision, and (3) whole organ excision.

Conclusions: The use of FGS as a surgical guide enhancement has the potential to improve survival and quality of life outcomes for patients. And, as the number of clinical trials rise each year, it is apparent that FGS has great potential for a broad range of clinical applications.

Citing Articles

Pressure-enhanced sensing of tissue oxygenation via endogenous porphyrin: Implications for dynamic visualization of cancer in surgery.

Petusseau A, Ochoa M, Reed M, Doyley M, Hasan T, Bruza P Proc Natl Acad Sci U S A. 2024; 121(34):e2405628121.

PMID: 39141355 PMC: 11348300. DOI: 10.1073/pnas.2405628121.


Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer.

Stone L, Kasten B, Rao S, Gonzalez M, Stevens T, Lin D Clin Cancer Res. 2024; 30(18):4016-4028.

PMID: 39012279 PMC: 11398989. DOI: 10.1158/1078-0432.CCR-24-0940.


A Phase 2 Multicenter Clinical Trial of Intraoperative Molecular Imaging of Lung Cancer with a pH-Activatable Nanoprobe.

Kennedy G, Azari F, Chang A, Bou-Samra P, Desphande C, Predina J Mol Imaging Biol. 2024; 26(4):585-592.

PMID: 38992245 DOI: 10.1007/s11307-024-01933-x.


Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors.

Giuliani S, Paraboschi I, McNair A, Smith M, Rankin K, Elson D Cancers (Basel). 2024; 16(5.

PMID: 38473402 PMC: 10931077. DOI: 10.3390/cancers16051045.


Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.

Mi J, Li C, Yang F, Shi X, Zhang Z, Guo L Ann Surg Oncol. 2023; 31(4):2451-2460.

PMID: 38063990 DOI: 10.1245/s10434-023-14677-9.


References
1.
Bertrand T, Cruz A, Binitie O, Cheong D, Letson G . Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?. Clin Orthop Relat Res. 2015; 474(3):677-83. PMC: 4746163. DOI: 10.1007/s11999-015-4359-x. View

2.
Meric F, Mirza N, Vlastos G, Buchholz T, Kuerer H, Babiera G . Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer. 2003; 97(4):926-33. DOI: 10.1002/cncr.11222. View

3.
Stenzl A, Burger M, Fradet Y, Mynderse L, Soloway M, Witjes J . Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010; 184(5):1907-13. PMC: 4327891. DOI: 10.1016/j.juro.2010.06.148. View

4.
Hauser S, Kockro R, Actor B, Sarnthein J, Bernays R . Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. Neurosurgery. 2015; 78(4):475-83. DOI: 10.1227/NEU.0000000000001035. View

5.
Colvin J, Zaidi N, Berber E . The utility of indocyanine green fluorescence imaging during robotic adrenalectomy. J Surg Oncol. 2016; 114(2):153-6. DOI: 10.1002/jso.24296. View